EUVIMEDEUVIMED entdecken
Crossref

Lysophospholipid Acyltransferase 9 Promotes Emphysema Formation via Platelet-activating Factor

Hiroaki Murano iD, Sumito Inoue iD, Tomomi Hashidate-Yoshida, Hideo Shindou iD, Takao Shimizu iD, Yoichiro Otaki iD, Yukihiro Minegishi, Takumi Kitaoka iD, Mitsuru Futakuchi iD, Akira Igarashi, Michiko Nishiwaki, Takako Nemoto und 6 weitere

American Journal of Respiratory Cell and Molecular Biology · 01.06.2024 · 70 (6) · 482-492

DOI: 10.1165/rcmb.2023-0253oc ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, online erschienen am 01.06.2024. Verfasst von Hiroaki Murano und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pulmonology, and Nephrology and. Hauptthemen laut MEDLINE: 1-Acylglycerophosphocholine O-Acyltransferase, Macrophages, Alveolar, Mice, Knockout, Platelet Activating Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Ministry of Education, Science, Sports, and Culture, Japan, Grant-in-Aid for Scientific Research, AMED-CREST, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cigarette smoking is known to be the leading cause of chronic obstructive pulmonary disease (COPD). However, the detailed mechanisms have not been elucidated. PAF (platelet-activating factor), a potent inflammatory mediator, is involved in the pathogenesis of various respiratory diseases such as bronchial asthma and COPD. We focused on LPLAT9 (lysophospholipid acyltransferase 9), a biosynthetic enzyme of PAF, in the pathogenesis of COPD. LPLAT9 gene expression was observed in excised COPD lungs and single-cell RNA sequencing data of alveolar macrophages (AMs). LPLAT9 was predominant and upregulated in AMs, particularly monocyte-derived AMs, in patients with COPD. To identify the function of LPLAT9/PAF in AMs in the pathogenesis of COPD, we exposed systemic LPLAT9-knockout (LPALT9−/−) mice to cigarette smoke (CS). CS increased the number of AMs, especially the monocyte-derived fraction, which secreted MMP12 (matrix metalloprotease 12). Also, CS augmented LPLAT9 phosphorylation/activation on macrophages and, subsequently, PAF synthesis in the lung. The LPLAT9−/− mouse lung showed reduced PAF production after CS exposure. Intratracheal PAF administration accumulated AMs by increasing MCP1 (monocyte chemoattractant protein-1). After CS exposure, AM accumulation and subsequent pulmonary emphysema, a primary pathologic change of COPD, were reduced in LPALT9−/− mice compared with LPLAT9+/+ mice. Notably, these phenotypes were again worsened by LPLAT9+/+ bone marrow transplantation in LPALT9−/− mice. Thus, CS-induced LPLAT9 activation in monocyte-derived AMs aggravated pulmonary emphysema via PAF-induced further accumulation of AMs. These results suggest that PAF synthesized by LPLAT9 has an important role in the pathogenesis of COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

1-Acylglycerophosphocholine O-AcyltransferaseMacrophages, AlveolarMice, KnockoutPlatelet Activating FactorPulmonary Disease, Chronic ObstructivePulmonary EmphysemaAnimalsFemaleHumansMaleMiceCigarette SmokingLungMatrix Metalloproteinase 12Mice, Inbred C57BL

Stichwörter der Autor:innen

chronic obstructive pulmonary diseasecigarette smokelysophospholipid acyltransferase 9monocyte-derived macrophageplatelet-activating factor

Substanzen

1-Acylglycerophosphocholine O-Acyltransferasematrix metallopeptidase 12, mouseMatrix Metalloproteinase 12Platelet Activating FactorLPCAT2 protein, humanLPCAT2 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Pulmonology, and Nephrology and.
  • Department of Lipid Life Science and.
  • Department of Medical Lipid Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; and.
  • Department of Lipid Signaling Project, National Center for Global Health and Medicine, Tokyo, Japan.
  • Institute of Microbial Chemistry, Tokyo, Japan.
  • Department of Pathology, Yamagata University Faculty of Medicine, Yamagata, Japan.

ORCID-Profile: Hiroaki Murano, Sumito Inoue, Hideo Shindou, Takao Shimizu, Yoichiro Otaki, Takumi Kitaoka, Mitsuru Futakuchi, Maki Kobayashi, Masafumi Watanabe

Förderung

  • Ministry of Education, Science, Sports, and Culture, Japan, Grant-in-Aid for Scientific Research
  • AMED-CREST
  • Takeda Science Foundation

Zitieren

APA

Murano, H., Inoue, S., Hashidate-Yoshida, T., Shindou, H., Shimizu, T., Otaki, Y., Minegishi, Y., Kitaoka, T., Futakuchi, M., Igarashi, A., Nishiwaki, M., Nemoto, T., Sato, M., Kobayashi, M., Sato, K., Hanawa, T., Miyazaki, O., & Watanabe, M. (2024). Lysophospholipid Acyltransferase 9 Promotes Emphysema Formation via Platelet-activating Factor. American Journal of Respiratory Cell and Molecular Biology, 70(6), 482-492. https://doi.org/10.1165/rcmb.2023-0253oc

Vancouver

Murano H, Inoue S, Hashidate-Yoshida T, Shindou H, Shimizu T, Otaki Y, et al. Lysophospholipid Acyltransferase 9 Promotes Emphysema Formation via Platelet-activating Factor. American Journal of Respiratory Cell and Molecular Biology. 2024;70(6):482-492. doi:10.1165/rcmb.2023-0253oc

BibTeX
@article{Murano2024,
  author = {Murano, Hiroaki and Inoue, Sumito and Hashidate-Yoshida, Tomomi and Shindou, Hideo and Shimizu, Takao and Otaki, Yoichiro and Minegishi, Yukihiro and Kitaoka, Takumi and Futakuchi, Mitsuru and Igarashi, Akira and Nishiwaki, Michiko and Nemoto, Takako and Sato, Masamichi and Kobayashi, Maki and Sato, Kento and Hanawa, Toshinari and Miyazaki, Osamu and Watanabe, Masafumi},
  title = {Lysophospholipid Acyltransferase 9 Promotes Emphysema Formation via Platelet-activating Factor},
  journal = {American Journal of Respiratory Cell and Molecular Biology},
  year = {2024},
  volume = {70},
  number = {6},
  pages = {482--492},
  doi = {10.1165/rcmb.2023-0253oc}
}
Kostenlos starten →